S. Mori et al., LIGAND-ACTIVATED PLATELET-DERIVED GROWTH-FACTOR BETA-RECEPTOR IS DEGRADED THROUGH PROTEASOME-DEPENDENT PROTEOLYTIC PATHWAY, Biochemical and biophysical research communications, 217(1), 1995, pp. 224-229
The platelet-derived growth factor beta-receptor undergoes polyubiquit
ination as a consequence of ligand binding. Ubiquitin conjugation to p
rotein is implicated in proteasome-dependent proteolytic pathway for s
hort-lived proteins. In the present study, we have examined effects of
different kinds of cell-penetrating proteasome inhibitors, including
isoleucyl-Y-t-butyl-L-glutamyl-L-alanyl-L-leucinal (PSI) and a Strepto
myces metabolite lactacystin, on ligand-stimulated degradation of the
beta-receptor. These proteasome inhibitors were found to considerably
inhibit the degradation of autophosphorylated and polyubiquitinated re
ceptors, suggesting the possible involvement of proteasomes in the deg
radation process of the ligand-activated beta-receptor. (C) 1995 Acade
mic Press, Inc.